New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
December 23, 2019 - Prasco launched an authorized brand alternative of Neos Therapeutics’ Adzenys ER (amphetamine) extended-release oral suspension.
Download PDF
Return to publications
